Further studies showed that MeCP2 binds to the promoter of G-protein-coupled receptor kinase-interacting protein 1 (GIT1), increases GIT1 protein expression, and activates the MEK1/2-ERK1/2 signaling pathway to promote gastric-cancer cell proliferation [120]. Here, MECP2 is linked to gastric cancer.